EVALUATION OF PHYSICOCHEMICAL PARAMETERS IMPORTANT TO THE ORAL BIOAVAILABILITY OF PEPTIDE-LIKE COMPOUNDS - IMPLICATIONS FOR THE SYNTHESIS OF RENIN INHIBITORS

被引:22
作者
HAMILTON, HW
STEINBAUGH, BA
STEWART, BH
CHAN, OH
SCHMID, HL
SCHROEDER, R
RYAN, MJ
KEISER, J
TAYLOR, MD
BLANKLEY, CJ
KALTENBRONN, JS
WRIGHT, J
HICKS, J
机构
[1] WARNER LAMBERT PARKE DAVIS,PARKE DAVIS PHARMACEUT RES,DEPT PHARMACOKINET DRUG METAB,ANN ARBOR,MI 48106
[2] WARNER LAMBERT PARKE DAVIS,PARKE DAVIS PHARMACEUT RES,DEPT PHARMACOL,ANN ARBOR,MI 48106
关键词
D O I
10.1021/jm00009a005
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of radiolabeled compounds related to renin inhibitor structures was synthesized to represent a range of physicochemical properties. These compounds were tested in assays for intestinal absorption and hepatic clearance in order to define parameters conducive to optimizing bioavailability. In general, compounds with higher Lipophilicity were better absorbed from the intestine. Absorption may also be dependent on molecular charge, as compounds with ionizable functionality were less well-absorbed than neutral compounds. Neutral compounds showed some dependency on molecular weight, with smaller compounds exhibiting better absorption. While uptake into hepatic cells was rapid regardless of partition coefficient or molecular weight, rate of appearance in bile was dependent on the molecular weight of the compounds.
引用
收藏
页码:1446 / 1455
页数:10
相关论文
共 31 条
[1]  
ABERNETHY DR, 1990, CLIN PHARMACOL THER, V47, P141
[2]   ESTIMATING HUMAN ORAL FRACTION DOSE ABSORBED - A CORRELATION USING RAT INTESTINAL-MEMBRANE PERMEABILITY FOR PASSIVE AND CARRIER-MEDIATED COMPOUNDS [J].
AMIDON, GL ;
SINKO, PJ ;
FLEISHER, D .
PHARMACEUTICAL RESEARCH, 1988, 5 (10) :651-654
[3]   CRYSTALLIZATION AND PRELIMINARY-X-RAY ANALYSIS OF COMPLEXES OF PEPTIDE INHIBITORS WITH HUMAN RECOMBINANT AND MOUSE SUBMANDIBULAR RENINS [J].
BADASSO, M ;
FRAZAO, C ;
SIBANDA, BL ;
DHANARAJ, V ;
DEALWIS, C ;
COOPER, JB ;
WOOD, SP ;
BLUNDELL, TL ;
MURAKAMI, K ;
MIYAZAKI, H ;
HOBART, PM ;
GEOGHEGAN, KF ;
AMMIRATI, MJ ;
LANZETTI, AJ ;
DANLEY, DE ;
OCONNOR, BA ;
HOOVER, DJ ;
SUEIRASDIAZ, J ;
JONES, DM ;
SZELKE, M .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 223 (02) :447-453
[4]  
BELMONT DT, 1992, Patent No. 5089616
[5]   THE INFLUENCE OF PEPTIDE STRUCTURE ON TRANSPORT ACROSS CACO-2 CELLS .2. PEPTIDE-BOND MODIFICATION WHICH RESULTS IN IMPROVED PERMEABILITY [J].
CONRADI, RA ;
HILGERS, AR ;
HO, NFH ;
BURTON, PS .
PHARMACEUTICAL RESEARCH, 1992, 9 (03) :435-439
[6]   RO-42-5892 IS A POTENT ORALLY ACTIVE RENIN INHIBITOR IN PRIMATES [J].
FISCHLI, W ;
CLOZEL, JP ;
ELAMRANI, K ;
WOSTL, W ;
NEIDHART, W ;
STADLER, H ;
BRANCA, Q .
HYPERTENSION, 1991, 18 (01) :22-31
[7]   AMINO ACIDS AND PEPTIDES .79. ALPHA-PYRROLO ANALOGUES OF ALPHA-AMINO ACIDS [J].
GLOEDE, J ;
PODUSKA, K ;
GROSS, H ;
RUDINGER, J .
COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 1968, 33 (04) :1307-&
[8]  
GRESK CJ, 1990, 3RD US CENTR REG M I
[9]   EVALUATION OF A SIMPLE HPLC CORRELATION METHOD FOR THE ESTIMATION OF THE OCTANOL-WATER PARTITION-COEFFICIENTS OF ORGANIC-COMPOUNDS [J].
HAKY, JE ;
YOUNG, AM .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1984, 7 (04) :675-689
[10]   EVALUATION OF THE INTESTINAL PERMEABILITY AND HEPATIC HANDLING OF PEPTIDOMIMETIC ANALOGS [J].
HAMILTON, H ;
STEINBAUGH, B ;
BLANKLEY, J ;
TAYLOR, M ;
CHAN, OH ;
STEWART, B ;
SCHROEDER, R ;
RYAN, M ;
RAPUNDALO, S ;
COOK, J ;
BERNABEI, A ;
STEWART, C .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1993, 3 (05) :813-818